119 related articles for article (PubMed ID: 4713488)
1. Possible acute liver toxicity from the hypolipidemic agent 1-methyl-4-piperidyl-bis(p-chlorophenoxy)-acetate.
Bochner F; Cham BE; Eadie MJ; Hooper WD; Knowles BR; Sutherland JM; Tyrer JH
Toxicol Appl Pharmacol; 1973 Apr; 24(4):653-6. PubMed ID: 4713488
[No Abstract] [Full Text] [Related]
2. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
Timms AR; Kelly LA; Ho RS; Trapold JH
Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
[No Abstract] [Full Text] [Related]
3. [Hepatotoxic effects of 2-methyl-2-(p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy)propionic acid (Ciba 13,437-Su)].
Kattermann R; Arnold R; Creutzfeldt W
Arzneimittelforschung; 1972 Mar; 22(3):616-9. PubMed ID: 4624899
[No Abstract] [Full Text] [Related]
4. Effect of halofenate on serum lipids.
Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
[No Abstract] [Full Text] [Related]
5. 1-methyl-4piperidyl-bis (P-chlorophenoxy) acetate: a new hypolipidemic peroxisome proliferator.
Reddy JK; Krishnakantha TP; Azarnoff DL; Moody DE
Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):589-92. PubMed ID: 1135523
[TBL] [Abstract][Full Text] [Related]
6. Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.
Salvador RA; Haber S; Atkins C; Gommi BW; Welch RM
Life Sci; 1970 Apr; 9(7):397-407. PubMed ID: 5445848
[No Abstract] [Full Text] [Related]
7. [Action of the new hypocholesteremic agent DH-581 (dithiobisphenol) in humans].
Brusco OJ; Oriozabala MA; Arakaki R
Prensa Med Argent; 1971 Oct; 58(32):1587-94. PubMed ID: 4943247
[No Abstract] [Full Text] [Related]
8. Effect of halofenate on serum uric acid.
Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP
Clin Pharmacol Ther; 1973; 14(3):371-3. PubMed ID: 4572799
[No Abstract] [Full Text] [Related]
9. [Studies on hypolipidemic agents. I. Syntheses and hypolipidemic activities of 2-(4'-chlorophenoxy)isobutyric acid derivatives (author's transl)].
Miyoshi F; Kuroda H; Hiraoka K; Fukami H; Onishi K
Yakugaku Zasshi; 1974 Mar; 94(3):387-96. PubMed ID: 4859114
[No Abstract] [Full Text] [Related]
10. [Nicotinic acid and the derivative].
Ogaki S; Matsushima T
Nihon Rinsho; 2001 Mar; 59 Suppl 3():637-41. PubMed ID: 11347146
[No Abstract] [Full Text] [Related]
11. [Effects of long acting fluvastatin on parameters of lipid metabolism in patients with type 2 diabetes and combined hyperlipidemia].
Kozlov SG; Liakishev AA; Titov VN; Naumov VG
Kardiologiia; 2004; 44(10):60-3. PubMed ID: 15477793
[No Abstract] [Full Text] [Related]
12. The effect of [4,4'-(isopropylidenethio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjects.
Drake JW; Bradford RH; McDearmon M; Furman RH
Metabolism; 1969 Nov; 18(11):916-25. PubMed ID: 5350556
[No Abstract] [Full Text] [Related]
13. The uricosuric action of halofenate (MK-185) in patients with hyperuricemia or uncomplicated primary gout and hyperlipidemia.
Hutchison JC; Wilkinson WH
Atherosclerosis; 1973; 18(3):353-62. PubMed ID: 4584481
[No Abstract] [Full Text] [Related]
14. Criteria for use of hypolipidemic agents in adults.
Morales E; Spinler SA; Wilson MD; Chin MM; Jozefiak E
Am J Hosp Pharm; 1994 Nov; 51(22):2837-41. PubMed ID: 7856612
[No Abstract] [Full Text] [Related]
15. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
[No Abstract] [Full Text] [Related]
16. Atorvastatin in the management of an index patient with complete hepatic lipase deficiency.
Hegele RA; Little JA; Connelly PW
Atherosclerosis; 1999 Mar; 143(1):219-22. PubMed ID: 10208500
[No Abstract] [Full Text] [Related]
17. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
18. [Hypolipidemic activity of trimethylglycine].
Kliueva NN; Kalashnikova NM; Okunevich IV; Sapronov NS
Eksp Klin Farmakol; 2012; 75(1):16-8. PubMed ID: 22442957
[TBL] [Abstract][Full Text] [Related]
19. The current status of hypolipidemic drugs.
Levy RI; Fredrickson DS
Postgrad Med; 1970 Jan; 47(1):130-6. PubMed ID: 5413128
[No Abstract] [Full Text] [Related]
20. [Diagnosis and treatment of hyperlipoidaemias].
Wolfram G
Munch Med Wochenschr; 1970 Oct; 112(40):1792 passim. PubMed ID: 5536214
[No Abstract] [Full Text] [Related]
[Next] [New Search]
